Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda

Sydney Rosen and colleagues describe an operations research agenda to accelerating uptake of HIV treatment initiation.

Vyšlo v časopise: Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda. PLoS Med 13(8): e32767. doi:10.1371/journal.pmed.1002106
Kategorie: Policy Forum
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002106

Souhrn

Sydney Rosen and colleagues describe an operations research agenda to accelerating uptake of HIV treatment initiation.

Zdroje

1. World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization; 2015.

2. Barnabas RV, Bendavid E, Bershteyn A, Boulle A, Eaton JW, Ford N, et al. HIV mortality by care cascade stage and implications for universal ART eligibility. Conference on Retroviruses and Opportunistic Infections 2016; 22–25 Feb 2016; Boston, Massachusetts, US. Available: http://www.croiconference.org/sessions/hiv-mortality-care-cascade-stage-and-implications-universal-art-eligibility.

3. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8:e1001056. doi: 10.1371/journal.pmed.1001056 21811403

4. Abdool Karim SS. Overcoming impediments to global implementation of early antiretroviral therapy. N Engl J Med. 2015;373 : 875–876. doi: 10.1056/NEJMe1508527 26193047

5. Lahuerta M, Ue F, Hoffman S, Elul B, Kulkarni SG, Remien RH, et al. The problem of late ART initiation in sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon? J Health Care Poor Underserved. 2013;24 : 359–383. doi: 10.1353/hpu.2013.0014 23377739

6. Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to ART care in sub-Saharan Africa: a systematic review. AIDS. 2012;26 : 2059–2067. doi: 10.1097/QAD.0b013e3283578b9b 22781227

7. Micek MA, Gimbel-Sherr K, Baptista AJ, Matediana E, Montoya P, Pfeiffer J, et al. Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr. 2009;52 : 397–405. doi: 10.1097/QAI.0b013e3181ab73e2 19550350

8. Scott V, Zweigenthal V, Jennings K. Between HIV diagnosis and initiation of antiretroviral therapy: assessing the effectiveness of care for people living with HIV in the public primary care service in Cape Town, South Africa. Trop Med Int Health. 2011;16 : 1384–1391. doi: 10.1111/j.1365-3156.2011.02842.x 21771213

9. Siedner MJ, Lankowski A, Haberer JE, Kembabazi A, Emenyonu N, Tsai AC, et al. Rethinking the “pre” in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs. PLoS ONE. 2012;7:e39894. doi: 10.1371/journal.pone.0039894 22761924

10. Hanifa Y, Fielding KL, Charalambous S, Variava E, Luke B, Churchyard GJ, et al. Tuberculosis among adults starting antiretroviral therapy in South Africa: the need for routine case finding. Int J Tuberc Lung Dis. 2012;16 : 1252–1259. doi: 10.5588/ijtld.11.0733 22794030

11. Pac L, Horwitz MM, Namutebi AM, Auerbach BJ, Semeere A, Namulema T, et al. Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia. J Acquir Immune Defic Syndr. 2015;68 : 5–11.

12. Longley N, Jarvis J, Meintjes G, Boulle A, Cross A, Kelly N, et al. Cryptococcal antigen screening in patients initiating ART in South Africa: a prospective cohort study. Clin Infect Dis. 2016;62 : 581–587. doi: 10.1093/cid/civ936 26565007

13. World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: World Health Organization; 2011.

14. Hosseinipour MC, Bisson GP, Miyahara S, Sun X, Moses A, Riviere C, et al. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial. Lancet. 2016;387 : 1198–1209. doi: 10.1016/S0140-6736(16)00546-8 27025337

15. TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373 : 808–822. doi: 10.1056/NEJMoa1507198 26193126

16. World Health Organization. Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children: recommendations for a public health approach. Geneva: World Health Organization; 2014.

17. Kim MH, Ahmed S, Hosseinipour MC, Giordano TP, Chiao EY, Yu X, et al. The impact of Option B+ on the antenatal PMTCT cascade in Lilongwe, Malawi. J Acquir Immune Defic Syndr. 2015;68 : 77–83.

18. Llenas-Garcia J, Wikman-Jorgensen P, Hobbins M, Mussa MA, Ehmer J, Keiser O, et al. Retention in care of HIV-infected pregnant and lactating women starting ART under Option B+ in rural Mozambique. Trop Med Int Health. 2016 May 21. doi: 10.1111/tmi.12728

19. Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G, et al. Initiating antiretroviral therapy for HIV at a patient’s first clinic visit: the RapIT randomized controlled trial. PLoS Med. 2016;13:e1002015. doi: 10.1371/journal.pmed.1002015 27163694

20. Amanyire G, Semitala FC, Namusobya J, Katuramu R, Kampiire L, Wallenta J, et al. Streamlining antiretroviral therapy uptake: a stepped-wedge cluster randomized trial. Boston: Conference on Retroviruses and Opportunistic Infections 2016; 22–25 Feb 2016; Boston, Massachusetts, US. Available: http://www.croiconference.org/sessions/streamlining-antiretroviral-therapy-uptake-stepped-wedge-cluster-randomized-trial.

21. Wilkinson L, Duvivier H, Patten G, Solomon S, Mdani L, Patel S, et al. Outcomes from the implementation of a counselling model supporting rapid antiretroviral treatment initiation in a primary healthcare clinic in Khayelitsha, South Africa. South Afr J HIV Med. 2015;16 : 1–7.

22. MacPherson P, Lalloo DG, Webb EL, Maheswaran H, Choko AT, Makombe SD, et al. Effect of optional home initiation of HIV care following HIV self-testing on antiretroviral therapy initiation among adults in Malawi: a randomized clinical trial. JAMA. 2014;312 : 372–379. doi: 10.1001/jama.2014.6493 25038356

23. Labhardt ND, Ringera I, Lejone TI, Masethothi P, T’sepang T, Mashaete K, et al. Same day ART initiation versus clinic-based pre-ART assessment and counselling for individuals newly tested HIV-positive during community-based HIV testing in rural Lesotho—a randomized controlled trial (CASCADE trial). BMC Public Health. 2016;16 : 329. doi: 10.1186/s12889-016-2972-6 27080120

24. MacKellar DA, Williams D, Storer N, Okello V, Azih C, Drummond J, et al. Enrollment in HIV care two years after HIV diagnosis in the Kingdom of Swaziland: an evaluation of a national program of new linkage procedures. PLoS ONE. 2016;11:e0150086. doi: 10.1371/journal.pone.0150086 26910847

25. Katz IT, Bangsberg DR. Cascade of refusal—what does it mean for the future of treatment as prevention in sub-Saharan Africa? Curr HIV/AIDS Rep. 2016;13 : 125–130. doi: 10.1007/s11904-016-0309-9 26894487

26. World Health Organization. HIV treatment and care: what’s new in monitoring. Geneva: World Health Organization; 2015.